TMCnet News
Short Sale Recap. Highest % Of Daily Trading Volume Short All Exchanges Combined For Tuesday(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET, www.buyins.net, has reviewed the NYSE, NASDAQ, BX, CHX and NSX Daily Short Volume Report for Tuesday, October 6th, 2009 and come to the following statistical conclusions. The chart below highlights 6 stocks that had unusually high percentages of their total daily trading volume attributed to short sales. SRS Labs (NASDAQ: SRSL), Ardea Biosciences (NASDAQ: RDEA), Information Services Group (NASDAQ: III), Internet Brands (NASDAQ: INET), Columbia Banking System (NASDAQ: COLB) and Cepheid (NASDAQ: CPHD). To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net. Symbol Short Volume Total Volume Percent SRSL 51,063 69,167 73.83% RDEA 35,867 61,200 58.61% III 33,106 63,800 51.89% INET 88,388 177,400 49.82% COLB 52,019 111,043 46.85% CPHD 177,152 395,082 44.84% In late October 2008 the SEC updated Regulation SHO requiring that all short sellers must locate, borrow and deliver any shares they have shorted, no exceptions, by T+3 settlement date. If not, a buy-in must be forced by the broker dealer that the short seller transacted through by the opening of the market on T+4. Since a company first appears on the naked short list when short sellers have been failing to deliver for 5 consecutive trading days, stocks should theoretically never be on the naked short list again. BUYINS.NET will monitor the exchangesa naked short lists daily and issue an alert and notify the SEC and FINRA should short sellers fail to deliver on any short sales. Reg SHO Rule 204 (i) requires brokers to deliver shares on long and short sales of publicly traded equity securities by settlement date, (ii) continues to require brokers to close-out fails to deliver by the beginning of trading on T+4 for short sales and T+6 for long sales, (iii) precludes clearing brokers and their introducing brokers from selling short a security, other than on a pre-borrowed basis, if a fail to deliver in that security is not timely closed out until the fail is closed out and that close-out transaction settles, (iv) allows clearing brokers to allocate fails to introducing brokers and (v) continues to permit brokers to rely upon pre-fail credit to satisfy Rule 204's close-out requirement to avoid the pre-borrow requirements when a fail at a clearing broker has not been closed out. However, the SEC liberalized certain of these provisions in several regards. For example, permanent Rule 204 now allows a broker to close-out a fail on a long sale by borrowing the security, whereas Rule 204T had only permitted closing out long fails by buying-in, which should alleviate some of the buy-in risk for investors that experience long fails. Similar relief was extended to close-outs for market maker fails, so that a fail from a bona fide market making transaction (including short and long fails) can now be closed out by the beginning of trading on T+6 by borrowing the security. Further, Rule 204 now permits a broker to borrow securities to obtain pre-fail credit for early close-outs, whereas temporary Rule 204T only permitted pre-fail credit to be obtained by purchases of securities. The SEC refused requests to extend the close-out deadline for fails to deliver to the close of business on the close-out deadline, choosing instead to retain the requirement that all fails be closed out by the beginning of trading on the applicable close-out deadline. The Commission also rejected requests for a fail to deliver exception that would have provided an exception from the close-out requirements if a clearing broker's fail position was below a certain amount but said that it would continue to monitor whether a de minimis or odd lot exception could be warranted. SRS Labs, Inc. (NASDAQ: SRSL), through its subsidiaries, engages in the development and provision of audio and voice technology solutions. The company principally develops and markets audio rendering, voice, and surround sound technologies to original equipment manufacturers, original design manufacturers, semiconductor manufacturers, and software providers. The companyas portfolio of licensable technologies includes Circle Surround, Audio Rendering, and Voice Processing. A surround sound technology, Circle Surround, is an encoding and decoding format. Circle surround encoding enables the distribution of up to 6.1 channels of audio over existing two-channel carriers, such as digital media files, standard definition and high-definition television, FM radio, and compact discs; and Circle Surround decoding decodes Circle Surround encoded material for multichannel playback or creates up to 6.1 channels of audio from older formats of material, including mono, stereo, 4-channel surround or other matrix surround formats. Audio Rendering technologies optimize device audio output and enable the presentation of 3D and multichannel audio content over two speakers. VIP and Noise Reduction technologies (Voice Processing) reduce noise to produce a clearer dialog over wireless communication devices and improve the intelligibility of the human voice in a variety of listening situations, including high ambient background environments. It serves home entertainment, portable media device, personal telecommunications, personal computer, automotive, and broadcast markets. The company sells its products and services in Korea, Japan, Americas, the People's Republic of China, the Asia Pacific, and Europe. It has a strategic partnership with Micro-Star Intl. Co. Ltd. to incorporate SRS Premium Sound within Micro-Star Intl. Co.as AP1900 and AE1900 all-in-one PCs to deliver music, video, and gaming. SRS Labs, Inc. was founded in 1993 and is headquartered in Santa Ana, California. Ardea Biosciences, Inc. (NASDAQ: RDEA), a biotechnology company, focuses on the discovery and development of small-molecule therapeutics for the treatment of gout, human immunodeficiency virus (HIV), cancer, and inflammatory diseases in the United States. The companyas lead product candidate includes RDEA594, a product for the treatment of hyperuricemia and gout. Its other products comprise RDEA806 for the treatment of patients with HIV; and RDEA427, a second-generation NNRTI for the treatment of HIV, in a human micro-dose pharmacokinetic study. Ardea Biosciences is evaluating RDEA119, a non-ATP EK inhibitor, in a Phase I/II study in combination with sorafenib and as a single agent in a Phase I study, both in advanced cancer patients. It also develops RDEA436 for the treatment of inflammation. The company is based in San Diego, California. Information Services Group, Inc. (NASDAQ: III) operates as a fact-based sourcing advisory firm principally in the Americas, Europe, and the Asia Pacific. The company specializes in the assessment, evaluation, negotiation, and management of service contracts related to outsourcing, insourcing, offshoring, and shared services between the companyas clients and outside service provider clients. These service contracts involve in the information technology (IT) infrastructure or software applications development; data and voice communications; or IT-enabled business processes, such as the internal finance and accounting functions, human resources, call center operations, or supply chain procurement. It serves industries, such as financial services, telecom, healthcare and pharmaceuticals, manufacturing, transportation and travel, and energy and utilities. The company was founded in 2006 and is based in Stamford, Connecticut. Internet Brands, Inc. (NASDAQ: INET), an Internet media company, owns, operates, and develops branded Web sites. It primarily operates automotive, careers, home, shopping, and travel and leisure Web sites. The companyas automotive Web sites capture various focused audiences, from those researching and purchasing new and used vehicles to the active communities of automotive enthusiasts. These Web sites include CarsDirect.com, Autos.com, and NewCarTestDrive.com. It also operates automotive-related community and user-generated content Web sites, which include AudiWorld.com, Ford-Trucks.com, CorvetteForum.com, and DodgeForum.com. The companyas careers Web sites provide visitors with various tools to help manage their careers. These Web sites include HospitalJobsOnline.com, CVTips.com, GrooveJob.com, ModelMayhem.com, PPRuNe.org, and WAHM.com. Its home-related Web sites provide access to content and services spanning the lifecycle of home-related activities. These Web sites include Mortgage101.com, DoItYourself.com, and ApartmentRatings.com. The companyas shopping category offers Web sites with information and resources to research purchases. These Web sites comprise AVRev.com, Bargainist.com, BensBargains.net, HighDefDigest.com, Steves-Digicams.com, and UltimateCoupons.com. Its travel and leisure Web sites comprise user communities that share travel and leisure-related experiences and interests, as well as offer resources, such as lodging or leisure activities. The companyas general travel community Web sites include Wikitravel.org, World66.com, FlyerTalk.com, and SlowTrav.com; and leisure Web sites include DVDTalk.com, BikeForums.net, and Puppydogweb.com. Internet Brands, Inc. also offers FitDay.com, an online resource for dieting and exercise. In addition, it licenses its content and Internet technology products and services, including customized products and services. The company was founded in 1998 and is headquartered in El Segundo, California. Columbia Banking System, Inc. (NASDAQ: COLB) operates as the holding company for Columbia State Bank, which provides a range of banking services to small and medium-sized businesses, professionals, and individuals in the states of Washington and Oregon. Its personal banking products and services include non-interest and interest bearing checking, savings, money market, and certificate of deposit accounts; online banking; fixed and variable rate home equity loans and lines of credit, home mortgages for purchases and refinances, personal loans, and other consumer loans; credit cards; private banking services, such as deposit and cash management, and credit and wealth management services; mutual funds, stocks, bonds, retirement accounts, annuities, tax-favored investments, the U.S. government securities, and long-term care and life insurance policies; and retirement and education financial planning services. The companyas business banking products and services consist of checking, savings, interest bearing money market, and certificate of deposit accounts; online banking; electronic bill payment services; remote deposit capture services; cash management services; commercial and industrial loans, and real estate and real estate construction loans; equipment finance; small business services; Visa card services; investment services; international banking services; and merchant card services. As of April 22, 2009, Columbia Banking System had 50 banking offices in Pierce, King, Cowlitz, Kitsap, Thurston, and Whatcom counties in Washington State, and Clackamas, Clatsop, Tillamook, and Multnomah counties in Oregon. The company was founded in 1988 and is headquartered in Tacoma, Washington. Cepheid (NASDAQ: CPHD), a molecular diagnostics company, develops, manufactures, and markets integrated systems for genetic testing in the clinical molecular diagnostic, industrial, and biothreat markets. Its systems enable molecular testing for organisms and genetic-based diseases by automation. Its SmartCycler system integrates DNA amplification and detection to allow rapid analysis of a sample; and GeneXpert system integrates sample preparation in addition to DNA amplification and detection. GeneXpert is designed for reference laboratories, hospital central laboratories, and satellite testing locations, such as ER and ICU units within hospitals, and doctorsa offices. In the clinical molecular diagnostic market, Cepheid markets tests for both the GeneXpert and the SmartCycler platforms in the areas of hospital acquired infections, critical infectious disease, immuno-compromised transplantation, womenas health, and oncology. These tests include Food and Drug Administration cleared products, such as in-vitro medical devices, CE Marked, analyte specific reagents, and research use only tests. In the industrial market, the company sells its SmartCycler along with general use polymerase chain reaction reagents and reaction tubes. Cepheid has tests available for anthrax, pestis, and tullarensis in the biothreat market. The company sells its products through direct sales and distribution channels worldwide. It has strategic relationship with bioMerieux, Inc. for bioMerieux to develop DNA testing products using nucleic acid sequence-based amplification technology. The company was founded in 1996 and is headquartered in Sunnyvale, California. About BUYINS.NET WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades. BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,650,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data. The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each monthas short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin. All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Occassionally companies or third parties pay $995 per month to purchase data for information provided in monthly reports. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. BUYINS.NET and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor. By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind. Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC. ((Comments on this story may be sent to [email protected])) (c) 2009 M2 COMMUNICATIONS |